Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compumedics Limited (AU:CMP)
ASX:CMP
Holding AU:CMP?
Track your performance easily
CMP Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.15 - AU$0.45
Previous CloseAU$0.31
Volume4.66K
Average Volume (3M)44.60K
Market Cap
AU$56.05M
Enterprise ValueAU$55.30M
Total Cash (Recent Filing)AU$7.29M
Total Debt (Recent Filing)AU$6.55M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume69,822
30 Day Avg. Volume44,596
Standard Deviation0.20
R-Squared0.21
Alpha-0.00500
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.65
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Compumedics Limited News
PremiumCompany Announcements
Compumedics Hits Record Revenues, Foresees Growth
PremiumCompany Announcements
Compumedics Triumphs with Major European Sales
PremiumCompany Announcements
Compumedics Limited Celebrates Record-Breaking Year
PremiumCompany Announcements
Compumedics Issues Shares to Investors
PremiumCompany Announcements
Compumedics Seeks Quotation for New SharesPremiumCompany Announcements
Compumedics Plans New Securities IssuancePremiumCompany Announcements
Compumedics Secures $1.9M for Sleep Test Expansion
PremiumCompany Announcements
Compumedics Limited Announces Trading HaltOptions Prices
Currently, No data available
---
Ownership Overview
55.26%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
44.74% Public Companies and
Individual Investors
CMP FAQ
What was Compumedics Limited’s price range in the past 12 months?
Compumedics Limited lowest share price was AU$0.14 and its highest was AU$0.45 in the past 12 months.
What is Compumedics Limited’s market cap?
Currently, no data Available
When is Compumedics Limited’s upcoming earnings report date?
Compumedics Limited’s upcoming earnings report date is Feb 26, 2025 which is in 159 days.
How were Compumedics Limited’s earnings last quarter?
Compumedics Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Compumedics Limited overvalued?
According to Wall Street analysts Compumedics Limited’s price is currently Overvalued.
Does Compumedics Limited pay dividends?
Compumedics Limited does not currently pay dividends.
What is Compumedics Limited’s EPS estimate?
Compumedics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Compumedics Limited have?
Compumedics Limited has 183,770,100 shares outstanding.
What happened to Compumedics Limited’s price movement after its last earnings report?
Compumedics Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Compumedics Limited?
Currently, no hedge funds are holding shares in AU:CMP
---
Compumedics Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
69.44%
12-Months-Change
Fundamentals
Return on Equity
-2.75%
Trailing 12-Months
Asset Growth
-2.51%
Trailing 12-Months
Company Description
Compumedics Limited
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for the sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and the Asia Pacific, and Europe. It derives a majority of revenue from Australia and the Asia Pacific region.
---
Technical Analysis
Resonance Health Ltd
―
Cyclopharm Limited
―
Medical Developments International Limited
―
---